Decreased mRNA and protein levels of PRKAR1A were observed in adenocarcinoma tissues, thereby instigating an in vitro experiment to assess if PRKAR1A was required for E-cadherin expression. The gene discussed is CDH1; the disease is adenocarcinoma.